CN Patent

CN101448843B — 用于疾病治疗的咪唑并噻唑化合物

Assigned to Ambit Bioscience Corp · Expires 2012-05-09 · 14y expired

What this patent protects

提供了用于调节受体激酶活性以及用于治疗、预防或缓解由受体激酶介导的疾病或病症的一种或多种症状的化合物、组合物和方法。

USPTO Abstract

提供了用于调节受体激酶活性以及用于治疗、预防或缓解由受体激酶介导的疾病或病症的一种或多种症状的化合物、组合物和方法。

Drugs covered by this patent

quizartinib-dihydrochloride (QUIZARTINIB DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN101448843B
Jurisdiction: CN
Classification: —
Expires: 2012-05-09
Drug substance claim: No
Drug product claim: No
Assignee: Ambit Bioscience Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.